$84.720
+5.109 (+6.03%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de SYRE por análisis de gráficos similares
Alphio's SYRE stock price prediction model matches the current Spyre Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $85.92 (+1.42%). The 1-week path is $84.42 (-0.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Spyre Therapeutics Inc?
Spyre Therapeutics Inc is currently a hold. The stock is priced at $79.90, which is significantly lower than the average analyst price target of $123. However, the RSI is at 37.725, indicating that the stock is currently oversold, while the recent insider selling (up 796.31%) raises concerns about confidence in the stock's near-term performance. The company has shown strong long-term growth with a 240.14% increase over the past year, but recent earnings reports have shown significant losses, with a net income of -69 million in Q1 2026.
SYRE cerró en $84.72 el Monday, tras subir +6.03%
Spyre Therapeutics Inc (SYRE) last closed at $84.72, gaining +6.03%. These facts feed the 1-day and 1-week SYRE price prediction above.
Factores de la previsión
Los factores de la previsión de Spyre Therapeutics Inc (SYRE) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de SYRE, ordenadas por similitud.
Análisis de estacionalidad de SYRE
Historically the probability of a positive October return for SYRE is 67.80%. December offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.